Back

VEGF beta is a candidate biomarker for cardiovascular risk stratification

26 August 2022 (16:15 - 17:00)
Organised by:
Congress Presentation Part of: Biomarkers and more Biomarkers ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Christian Schulte

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

8 More presentations in this session

Presentation thumbnail
Patients with known coronary artery disease who are ruled out for acute myocardial infarction using a high sensitivity troponin T 0/1-hour algorithm have increased 30-day major adverse cardiac events
Professor R. Nowak (Detroit, US)
Abstract Slides
Presentation thumbnail
Differences in circulating cardiac troponin I and T in acute and chronic cardiac disease
Doctor T. Zimmermann (Basel, CH)
Abstract Slides
Presentation thumbnail
Growth differentiation factor 15 at 3 months after an acute chest pain admission is associated with increased risk of death and cardiovascular events
Doctor G. Myrmel (Bergen, NO)
Abstract Slides
Presentation thumbnail
Direct comparison of very early AMI rule-out algorithms
Doctor C. Pedersen (Aarhus, DK)
Abstract Slides
Presentation thumbnail
Serial high-sensitivity troponin T concentrations and long-term outcomes in patients with suspected acute coronary syndrome
Doctor A. Kristensen (Frederiksberg, DK) Doctor M. Pareek (Copenhagen, DK)
Abstract Slides

Access the full session

Session thumbnail
Biomarkers and more

The Event

Event poster

ESC Congress 2022

26 August 2022 16:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources